𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients

✍ Scribed by Ana O. Hoff; Bela Toth; Mimi Hu; Gabriel N. Hortobagyi; Robert F. Gagel

Book ID
110108416
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
116 KB
Volume
1218
Category
Article
ISSN
0890-6564

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Incidence and risk factors of bisphospho
Incidence and risk factors of bisphosphonate-associated osteonecrosis of the jaws
✍ Matthew R. Stumpe; Rakesh K. Chandra; Furhan Yunus; Sandeep Samant πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 108 KB πŸ‘ 2 views

## Abstract ## Background Intravenous bisphosphonate therapy has been used for treatment of benign and malignant bone diseases and has been linked to osteonecrosis of the jaws. ## Methods Records of 638 patients treated with intravenous bisphosphonates were reviewed. Drug used, number of infusio

Bisphosphonate-related osteonecrosis of
Bisphosphonate-related osteonecrosis of the jaw and its associated risk factors: A belgian case series
✍ Sven Saussez; Rokneddine Javadian; ChloΓ© Hupin; MichΓ¨le Magremanne; Gilbert Chan πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 216 KB πŸ‘ 1 views

## Abstract ## Objectives: Bisphosphonate‐related osteonecrosis of the jaw (BROJ) is a serious oral complication of bisphosphonate (BP) treatment involving the exposure of necrotic maxillary or mandibular bone. Our purpose is to describe the clinical presentation of 34 cases of BROJ and to identif